Skip to main content

Table 1 Baseline characteristics of 799 patients included in the study

From: Effect of pulmonary rehabilitation on lung cancer surgery outcomes: a matched-case analysis

Characteristic

Pulmonary rehabilitation (PR) (n = 61)

Non-intervention or control (NG) (n = 738)

Patient demographics

 Age

71 (66, 75)

70 (63, 75)

 Gender (male)

26 (43%)

383 (52%)

 BMI

25.2 (22.8, 28.5)

26.9 (24.0, 30.3)

BMI classification

 Healthy weight

26 (43%)

212 (29%)

 Obese

9 (15%)

180 (24%)

 Overweight

21 (34%)

296 (40%)

 Severely obese

1 (1.6%)

16 (2.2%)

 Underweight

4 (6.6%)

34 (4.6%)

Smoking status

 Current

9 (15%)

76 (10%)

 Ex-smoker

42 (69%)

512 (70%)

 Never smoker

10 (16%)

142 (19%)

 Pack years

40 (15, 50)

28 (5, 45)

 Unknown pack years

9

46

Lung function

 FEV1 (L)

2.14 (1.70, 2.55)

2.02 (1.56, 2.30)

 % FEV1

87 (74, 100)

81 (66, 99)

 %DLCO

77 (65, 91)

71 (58, 84)

 PpoFEV1

69 (56, 81)

62 (46, 81)

 PpoDLCO

61 (51, 73)

57 (48, 66)

Surgical incision

 Open

37 (61%)

327 (44%)

 VATS

24 (39%)

409 (56%)

Surgery side

 Right

43 (70%)

425 (58%)

Lobe

 Upper

37 (63%)

402 (56%)

 Middle

2 (3.4%)

44 (6.1%)

 Lower

15 (25%)

227 (31%)

 Upper bilobe

4 (6.8%)

10 (1.4%)

 Lower bilobe

0

5 (0.7%)

 Entire lung

1 (1.7%)

26 (3.6%)

Lung resection

 Wedge

10 (16%)

129 (17%)

 Segmentectomy

2 (3.3%)

23 (3.1%)

 Lobectomy

45 (74%)

539 (73%)

 Bilobectomy

3 (4.9%)

18 (2.4%)

 Sleeve

0

3 (0.4%)

 Pneumonectomy

1 (1.6%)

26 (3.5%)

Comorbidity

 COPD

27 (44%)

132 (18%)

 Hypertension

20 (34%)

316 (46%)

Other measures

 MRC dyspnoea score > 2

4 (6.6%)

21 (3%)

Rehabilitation sessions

 Pre-surgery

2 (1, 5)

 

 Post-surgery

0 (0, 2)

 

Perioperative outcomes

 Postoperative pulmonary complications

7 (11%)

46 (6.2%)

 Hospital length of stay (days)

5.0 (4.0, 7.0)

4.00 (3.00, 6.00)

  1. Data are presented as mean (median), standard deviation (interquartile range), or numbers and percentages for categorical data
  2. FEV1 forced expiratory volume for 1 s, DLCO diffusing capacity for carbon monoxide, PpoFEV1 or PpoDLCO predicted postoperative FEV1 or DLCO, VATS video-assisted thoracic surgery, COPD chronic obstructive pulmonary disease